Ingevity (NGVT)


Market Price (8/8/2026): $77.815 | Market Cap: $2.7 BilSector: Materials | Industry: Specialty Chemicals

Ingevity (NGVT)


Market Price (8/8/2026): $77.815
Market Cap: $2.7 Bil
Sector: Materials
Industry: Specialty Chemicals

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 18%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%

Attractive yield
FCF Yield is 5.7%

Low stock price volatility
Vol 12M is 37%

Megatrend and thematic drivers
Megatrends include Advanced Materials, and Sustainable Resource Management. Themes include Specialty Chemicals for Performance, Resource Efficiency Solutions, Show more.

Trading close to highs
Dist 52W High is -0.1%, Dist 3Y High is -0.1%

Weak multi-year price returns
3Y Excs Rtn is -45%

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 50x

Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -1.4%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -10%, Rev Chg QQuarterly Revenue Change % is -5.2%

Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.4%

Key risks
NGVT key risks include [1] the long-term challenge to its core automotive carbon business from the market's transition to electric vehicles, Show more.

0 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 18%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 13%
1 Attractive yield
FCF Yield is 5.7%
2 Low stock price volatility
Vol 12M is 37%
3 Megatrend and thematic drivers
Megatrends include Advanced Materials, and Sustainable Resource Management. Themes include Specialty Chemicals for Performance, Resource Efficiency Solutions, Show more.
4 Trading close to highs
Dist 52W High is -0.1%, Dist 3Y High is -0.1%
5 Weak multi-year price returns
3Y Excs Rtn is -45%
6 Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 25x, P/EPrice/Earnings or Price/(Net Income) is 50x
7 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -1.4%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -10%, Rev Chg QQuarterly Revenue Change % is -5.2%
8 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.4%
9 Key risks
NGVT key risks include [1] the long-term challenge to its core automotive carbon business from the market's transition to electric vehicles, Show more.

NGVT in ETFs

Weight = NGVT's share of each fund

ITOT0.00%
IWM0.09%
IJR0.14%
VB0.03%
IWO0.17%
IJT0.17%
SLYG0.16%
FNDA0.12%
+11 more covered ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Updated on 8/5/2026

Ingevity (NGVT) stock has remained largely at the same level since 4/30/2026 because of the following key factors:

1. Strong Second Quarter 2026 Financial Performance and Upbeat Outlook. Ingevity reported adjusted earnings per share (EPS) of $1.74 for fiscal Q2 2026 (ended June 2026), significantly beating the Zacks Consensus Estimate of $1.31 by 32.82%. Revenue of $314.1 million also surpassed estimates by 4.91%. The company's adjusted EBITDA increased nearly 14% to $115.0 million, with margins expanding to 36.6%, leading management to raise its full-year 2026 adjusted EBITDA guidance to between $380 million and $400 million and diluted adjusted EPS to $5.00-$5.45. This positive company-specific news provided a strong floor for the stock.

2. Strategic Portfolio Transformation through Divestiture. The completion of the Road Markings product line divestiture on April 15, 2026, significantly impacted reported sales within the analysis period. While reported net sales for fiscal Q2 2026 decreased 5% year-over-year to $314.1 million, sales excluding the divested business actually increased over 5% with growth across all three operating segments. This strategic move aims to enhance the company's margin profile and focus on higher-growth specialty chemicals, contributing to investor confidence despite the headline sales decrease.

Show more
Updated on 8/5/2026

Ingevity (NGVT) stock has remained largely at the same level since 4/30/2026 because of the following key factors:

1. Strong Second Quarter 2026 Financial Performance and Upbeat Outlook. Ingevity reported adjusted earnings per share (EPS) of $1.74 for fiscal Q2 2026 (ended June 2026), significantly beating the Zacks Consensus Estimate of $1.31 by 32.82%. Revenue of $314.1 million also surpassed estimates by 4.91%. The company's adjusted EBITDA increased nearly 14% to $115.0 million, with margins expanding to 36.6%, leading management to raise its full-year 2026 adjusted EBITDA guidance to between $380 million and $400 million and diluted adjusted EPS to $5.00-$5.45. This positive company-specific news provided a strong floor for the stock.

2. Strategic Portfolio Transformation through Divestiture. The completion of the Road Markings product line divestiture on April 15, 2026, significantly impacted reported sales within the analysis period. While reported net sales for fiscal Q2 2026 decreased 5% year-over-year to $314.1 million, sales excluding the divested business actually increased over 5% with growth across all three operating segments. This strategic move aims to enhance the company's margin profile and focus on higher-growth specialty chemicals, contributing to investor confidence despite the headline sales decrease.

3. Ongoing Share Repurchase Program and Improved Balance Sheet. Ingevity demonstrated its commitment to shareholder returns by repurchasing approximately $35 million of shares during fiscal Q2 2026 at a weighted average price of $70.94 per share. Approximately $211 million remains under its current authorization, and the company is ahead of pace toward its goal of repurchasing $300 million of shares by the end of 2027. Additionally, net leverage improved to 2.5 times, reaching the upper end of the company's stated target range. This financial discipline and capital allocation supported the stock's stability.

4. Robust Demand in Performance Materials Segment, Driven by Hybrid Vehicle Market. The Performance Materials segment, a key driver for Ingevity, reported sales of $161 million in fiscal Q2 2026, a 4% increase year-over-year. This growth was primarily fueled by higher volumes, a favorable product mix, and annual pricing actions, supported by the ongoing consumer preference shift from battery electric vehicles towards hybrids. This company-specific demand for advanced activated carbon solutions provided a consistent revenue stream and segment EBITDA growth of 6% to $86 million, reinforcing the stock's underlying value.

Show less
Holding a concentrated position? Know your true downside before the momentum shifts.
Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 2.1% change in NGVT stock from 4/30/2026 to 8/7/2026 was primarily driven by a 3.0% change in the company's Shares Outstanding (Mil).
(LTM values as of)43020268072026Change
Stock Price ($)76.1977.822.1%
Change Contribution By: 
Total Revenues ($ Mil)1,1681,160-0.6%
P/S Multiple2.32.3-0.2%
Shares Outstanding (Mil)36353.0%
Cumulative Contribution2.1%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2026 to 8/7/2026
ReturnCorrelation
NGVT2.1% 
Market (SPY)7.6%36.3%
Sector (XLB)2.7%49.3%

Fundamental Drivers

The 18.3% change in NGVT stock from 1/31/2026 to 8/7/2026 was primarily driven by a 14.5% change in the company's P/S Multiple.
(LTM values as of)13120268072026Change
Stock Price ($)65.7977.8218.3%
Change Contribution By: 
Total Revenues ($ Mil)1,1761,160-1.3%
P/S Multiple2.02.314.5%
Shares Outstanding (Mil)36354.7%
Cumulative Contribution18.3%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 8/7/2026
ReturnCorrelation
NGVT18.3% 
Market (SPY)12.1%40.3%
Sector (XLB)7.8%61.8%

Fundamental Drivers

The 86.2% change in NGVT stock from 7/31/2025 to 8/7/2026 was primarily driven by a 89.1% change in the company's P/S Multiple.
(LTM values as of)73120258072026Change
Stock Price ($)41.7977.8286.2%
Change Contribution By: 
Total Revenues ($ Mil)1,2361,160-6.1%
P/S Multiple1.22.389.1%
Shares Outstanding (Mil)36354.9%
Cumulative Contribution86.2%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2025 to 8/7/2026
ReturnCorrelation
NGVT86.2% 
Market (SPY)23.4%33.4%
Sector (XLB)22.2%52.8%

Fundamental Drivers

The 21.6% change in NGVT stock from 7/31/2023 to 8/7/2026 was primarily driven by a 323.3% change in the company's P/E Multiple.
(LTM values as of)73120238072026Change
Stock Price ($)64.0277.8221.6%
Change Contribution By: 
Total Revenues ($ Mil)1,6781,160-30.9%
Net Income Margin (%)12.0%4.7%-61.2%
P/E Multiple11.850.0323.3%
Shares Outstanding (Mil)37357.1%
Cumulative Contribution21.6%

LTM = Last Twelve Months as of date shown

Market Drivers

7/31/2023 to 8/7/2026
ReturnCorrelation
NGVT21.6% 
Market (SPY)74.9%45.4%
Sector (XLB)30.2%56.6%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
NGVT Return-5%-2%-33%-14%45%31%2%
Peers Return22%-4%6%-3%-21%25%17%
S&P 500 Return27%-19%24%23%16%13%105%

Monthly Win Rates [3]
NGVT Win Rate50%50%50%50%50%62% 
Peers Win Rate55%43%45%48%35%68% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
NGVT Max Drawdown-22%-25%-59%-43%-39%-17% 
Peers Max Drawdown-20%-27%-29%-23%-35%-22% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: CBT, EMN, ASH, SCL, RPM. See NGVT Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 8/7/2026 (YTD)

How Low Can It Go

EventNGVTS&P 500
2025 US Tariff Shock
  % Loss-38.1%-18.8%
  % Gain to Breakeven61.5%23.1%
  Time to Breakeven119 days79 days
2024 Yen Carry Trade Unwind
  % Loss-16.8%-7.8%
  % Gain to Breakeven20.2%8.5%
  Time to Breakeven79 days18 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-40.2%-9.5%
  % Gain to Breakeven67.3%10.5%
  Time to Breakeven789 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-24.4%-24.5%
  % Gain to Breakeven32.3%32.4%
  Time to Breakeven158 days427 days
2020 COVID-19 Crash
  % Loss-57.3%-33.7%
  % Gain to Breakeven134.1%50.9%
  Time to Breakeven236 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-23.2%-19.2%
  % Gain to Breakeven30.2%23.8%
  Time to Breakeven52 days105 days

Compare to CBT, EMN, ASH, SCL, RPM

In The Past

Ingevity's stock fell -38.1% during the 2025 US Tariff Shock. Such a loss loss requires a 61.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventNGVTS&P 500
2025 US Tariff Shock
  % Loss-38.1%-18.8%
  % Gain to Breakeven61.5%23.1%
  Time to Breakeven119 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-40.2%-9.5%
  % Gain to Breakeven67.3%10.5%
  Time to Breakeven789 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-24.4%-24.5%
  % Gain to Breakeven32.3%32.4%
  Time to Breakeven158 days427 days
2020 COVID-19 Crash
  % Loss-57.3%-33.7%
  % Gain to Breakeven134.1%50.9%
  Time to Breakeven236 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-23.2%-19.2%
  % Gain to Breakeven30.2%23.8%
  Time to Breakeven52 days105 days

Compare to CBT, EMN, ASH, SCL, RPM

In The Past

Ingevity's stock fell -38.1% during the 2025 US Tariff Shock. Such a loss loss requires a 61.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ingevity (NGVT)

Ingevity Corporation (NGVT) is a global specialty chemicals and materials company that develops and manufactures high-performance products for a wide range of industrial and consumer applications. The company leverages both natural resources, such as hardwood and crude tall oil, and advanced chemical synthesis to create its diverse portfolio. Ingevity's operations are divided into two key segments: Performance Materials and Performance Chemicals.

The Performance Materials segment specializes in engineering and manufacturing activated carbon products. These products are predominantly utilized in gasoline vapor emission control systems for automotive and marine vehicles, helping meet stringent environmental regulations. Additionally, this segment supplies activated carbon for critical purification processes across various industries, including food, water, beverage, and general chemical purification.

The Performance Chemicals segment focuses on producing a broad array of chemicals, many derived from crude tall oil and lignin, byproducts of the kraft pulping process, as well as caprolactone monomers and derivatives. This segment's offerings include advanced pavement technologies used in road construction, preservation, and recycling; industrial specialties for applications like oil well services, adhesives, lubricants, and printing inks; and engineered polymers for high-value uses in coatings, resins, elastomers, bioplastics, and medical devices, serving a diverse global market.

AI Analysis | Feedback

Here are 1-3 brief analogies for Ingevity (NGVT):
  • Ingevity is like Eastman Chemical for specialty materials, but with a unique focus on activated carbon for reducing car emissions and performance chemicals for making roads last longer.
  • They're similar to Cabot Corporation, providing specialized carbon materials and performance chemicals that are essential for cleaning car emissions and creating more durable road infrastructure.

AI Analysis | Feedback

```html
  • Activated Carbon for Emission Control: Hardwood-based and chemically activated carbon products primarily used in gasoline vapor emission control systems for vehicles.
  • Activated Carbon for Purification: Activated carbon products utilized in food, water, beverage, and chemical purification applications.
  • Pavement Technologies: Products derived from crude tall oil and lignin used in warm mix paving, pavement preservation, and reconstruction.
  • Industrial Specialty Chemicals: Specialty chemicals used as oil well service additives, in adhesives, agrochemical dispersants, lubricants, and coatings.
  • Engineered Polymers: Caprolactone monomers and derivatives used in the production of elastomers, bioplastics, and medical devices.
```

AI Analysis | Feedback

Ingevity (NGVT) primarily sells its specialty chemicals and activated carbon materials to other companies (B2B) across a wide range of industries globally.

Based on Ingevity's public financial disclosures, the company does not have any single major customer that accounts for 10% or more of its net sales. This indicates a highly diversified customer base rather than reliance on a few dominant buyers.

While no individual major customer names are disclosed due to this diversification, Ingevity's products are integral to operations within the following broad categories of customer companies:

  • Automotive Manufacturers and Suppliers: Utilizing activated carbon for gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.
  • Industrial and Purification Companies: Including those in food, water, beverage, and chemical purification, as well as manufacturers requiring industrial specialties like adhesives, agrochemical dispersants, lubricants, printing inks, and coatings.
  • Infrastructure and Construction Firms: Using pavement technologies for applications such as warm mix paving, pavement preservation, reconstruction, and recycling.
  • Oil and Gas Sector: Employing products for oil well service additives, oil production, and various downstream applications.
  • Engineered Polymers and Medical Device Manufacturers: Utilizing caprolactone monomers and derivatives for resins, elastomers, bioplastics, and medical devices.

AI Analysis | Feedback

Ingevity Major Suppliers
  • WestRock (WRK)

AI Analysis | Feedback

David H. Li, President and CEO

David H. Li was appointed President and CEO of Ingevity, effective April 7, 2025. He brings over 25 years of experience in the specialty materials industry. Prior to joining Ingevity, he served as CEO, president, and a member of the board of CMC Materials, Inc. from January 2015 until its sale to Entegris, Inc. in 2022. During his tenure at CMC Materials, the company delivered a significant return to stockholders. He is recognized for his track record of repositioning businesses to achieve substantial growth, strong financial performance, and outstanding stockholder returns.

Mary Dean Hall, Executive Vice President and Chief Financial Officer

Mary Dean Hall joined Ingevity in April 2021 as Executive Vice President and Chief Financial Officer. She will transition from her current role effective May 1, 2026, and will continue in an advisory capacity for one year. Before Ingevity, she was CFO and Treasurer at Quaker Houghton from 2015 to April 2021. Her earlier career includes a 20-year tenure at Eastman Chemical Company, where she held various senior-level financial positions, including Vice President and Treasurer. She also held financial and banking positions at Nalco Chemical Company and with banks such as Citibank and First Chicago (now J.P. Morgan). Ms. Hall serves on the board of directors for Applied Industrial Technologies.

Phillip J. Platt, Senior Vice President, Finance and Chief Accounting Officer (Incoming Chief Financial Officer)

Phillip J. Platt is currently Ingevity's Senior Vice President, Finance and Chief Accounting Officer, and is appointed to succeed Mary Dean Hall as Senior Vice President and CFO, effective May 1, 2026. He joined Ingevity in 2015 as Chief Accounting Officer and Corporate Controller. Since then, he has held key finance leadership roles, including Vice President of Financial Planning and Business Transformation Lead, and has overseen Financial Reporting and Analysis, Treasury, Investor Relations, and Business Transformation.

Ruth Castillo, Senior Vice President and President, Performance Materials

Ruth Castillo serves as Senior Vice President and President of Performance Materials at Ingevity. Additional specific background details were not available in the provided search results.

Reid Clontz, Senior Vice President, Operations

Reid Clontz was appointed Senior Vice President, Operations, and a member of Ingevity's executive leadership team, effective December 8, 2025. He previously served as Vice President, Global Operations at Ingevity. Mr. Clontz brings more than two decades of experience in the chemical industry to his role, leading operations across multiple manufacturing sites, improving process efficiency, and aligning production with sustainability goals. In his current position, he also oversees the company's supply chain, procurement, and safety functions.

AI Analysis | Feedback

Here are the key risks to Ingevity's business:

  1. Transition to Electric Vehicles (EVs): A significant portion of Ingevity's Performance Materials segment relies on producing activated carbon for gasoline vapor emission control systems in traditional internal combustion engine vehicles. The accelerating global shift toward electric vehicles (EVs), which do not require these systems, presents a fundamental long-term threat to demand in this core business area. While Ingevity is exploring opportunities related to EV battery systems and advanced filtration technologies for electric vehicles, this is an evolving market, and its growth may not fully offset the decline in demand from gasoline-powered vehicles.

  2. Raw Material Volatility and Supply Chain Disruptions: Ingevity's Performance Chemicals segment, and its overall operations, are heavily dependent on specific bio-based raw materials, particularly crude tall oil (CTO), a byproduct of the pulp and paper industry. The company has experienced significant increases in CTO costs in the past, which negatively impacted its financial results. The limited supply or lack of access to sufficient raw materials, coupled with price volatility, especially with rising demand for CTO in the biofuel industry, poses an ongoing risk to production costs and profitability.

  3. Regulatory Changes and Environmental Scrutiny: As a manufacturer of specialty chemicals and activated carbon, Ingevity operates in a highly regulated industry. The company is exposed to risks associated with evolving environmental laws, air quality standards, and other regulations, including those related to greenhouse gas emissions. Compliance with these changing regulations can lead to increased operational costs, necessitate significant capital expenditures for facility upgrades, or require costly adaptations of its products and manufacturing processes.

AI Analysis | Feedback

null

AI Analysis | Feedback

Ingevity Corporation operates in several addressable markets for its specialty chemicals and activated carbon materials. The market sizes for its main products and services are as follows:

Performance Materials Segment

  • Automotive Activated Carbon Canisters: The global market for activated carbon for automotive applications, primarily for gasoline vapor emission control systems, was valued at approximately USD 291.12 million in 2024 and is projected to reach USD 514.5 million by 2034. North America holds the largest market share, at approximately 45%.
  • Activated Carbon for Purification (Food, Water, Beverage, and Chemical Purification): The global activated carbon market size was estimated at USD 4,068.8 million in 2025 and is projected to reach USD 5,497.3 million by 2033. Another source indicates a global market size of USD 4.9 billion in 2024, expected to reach USD 8.8 billion in 2032. The water treatment segment accounted for the largest revenue share of 42.5% in 2025. The Asia Pacific region dominated the overall activated carbon industry with a 48.9% share in 2025.

Performance Chemicals Segment

  • Crude Tall Oil (CTO) Derivatives: The global crude tall oil derivative market size reached USD 2.1 billion in 2024 and is expected to reach USD 3.0 billion by 2033. Another report estimates the market at USD 3.27 billion in 2024, projected to reach USD 5.00 billion by 2035. North America is the largest market for crude tall oil derivatives, holding approximately 45% of the global market share.
  • Warm Mix Asphalt (Pavement Technologies): The global warm mix asphalt market size was estimated at USD 8.257 billion in 2024 and is projected to grow to USD 10.2 billion by 2035. North America held a majority share, valued at USD 3.0 billion in 2024, and is expected to reach USD 3.7 billion by 2035.
  • Pavement Rejuvenators (Pavement Preservation): The global pavement rejuvenators market size reached USD 5.2 billion in 2024 and is projected to expand to USD 8.6 billion by 2033. North America remains the dominant regional market, accounting for approximately USD 2.1 billion in 2024.
  • Caprolactone (Engineered Polymers): The global caprolactone market size was over USD 329.55 million in 2025 and is anticipated to cross USD 630.33 million by 2035. Another estimate places the global caprolactone market size at USD 256.69 million in 2024, anticipated to reach USD 289.159 million by 2032. The Asia Pacific region holds the largest revenue share in the caprolactone market.

AI Analysis | Feedback

Ingevity Corporation (NGVT) is expected to drive future revenue growth over the next 2-3 years through a combination of strategic pricing, expansion in its core Performance Chemicals segment, and potential tailwinds from the automotive industry. Here are 3-5 expected drivers of future revenue growth:
  • Price Increases in Performance Materials: Ingevity anticipates low single-digit sales growth in its Performance Materials segment for 2026, primarily supported by disciplined price increases in its automotive product lines. This segment manufactures activated carbon products used in gasoline vapor emission control systems.
  • Growth in Performance Chemicals Core Businesses: The company projects mid-single-digit sales growth for its Performance Chemicals segment in 2026, which includes its Pavement Technologies product line. This growth is expected to stem from focusing on core, higher-value applications within this segment, following recent strategic repositioning actions such as the sale of its Industrial Specialties product line.
  • Recovery in Global Automotive Production: While 2025 experienced volatility and lower auto production impacting volumes, the Performance Materials segment demonstrated resilience through pricing actions. A potential recovery and stabilization in global automotive manufacturing volumes in the coming years would provide an additional tailwind for this segment, complementing the expected growth from price increases.
  • Benefits from Strategic Portfolio Optimization: Ingevity's ongoing efforts to optimize its portfolio through divestitures of non-core assets, such as the North Charleston crude tall oil refinery and the majority of its Industrial Specialties product line, are aimed at creating a more focused and agile enterprise. Although these actions may initially impact top-line revenue, they are expected to enhance the company's position in higher-margin, specialized markets, ultimately supporting more sustainable and profitable revenue growth in its core businesses over the next 2-3 years.

AI Analysis | Feedback

Share Repurchases

  • Ingevity deployed $56 million to repurchase approximately 1 million shares in 2025.
  • As of year-end 2025, the company had a remaining share repurchase authorization of just under $300 million.
  • Ingevity plans to complete $300 million in share repurchases through 2027, including almost $20 million already repurchased in the first quarter of 2026.

Share Issuance

  • Ingevity granted 3,688 shares of common stock as restricted stock units to a senior executive in March 2026, vesting in equal installments from 2027 to 2029.

Capital Expenditures

  • Capital expenditures were $54 million in 2025, $78 million in 2024, $110 million in 2023, $143 million in 2022, and $104 million in 2021.
  • Capital expenditures for 2026 are expected to be consistent with 2025, in the range of $40 million to $60 million.

Better Bets vs. Ingevity (NGVT)

Latest Trefis Analyses

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

NGVTCBTEMNASHSCLRPMMedian
NameIngevity Cabot Eastman .Ashland Stepan RPM Inte. 
Mkt Price77.8287.6273.6476.4565.15117.3677.13
Mkt Cap2.74.58.43.51.514.94.0
Rev LTM1,1603,6348,8651,8422,4337,8633,033
Op Inc LTM28449387512581966389
FCF LTM15528153920637675244
FCF 3Y Avg12634351717925707261
CFO LTM211497991291155899394
CFO 3Y Avg1985911,103297158930444

Growth & Margins

NGVTCBTEMNASHSCLRPMMedian
NameIngevity Cabot Eastman .Ashland Stepan RPM Inte. 
Rev Chg LTM-1.4%-4.7%-4.5%-1.4%7.6%6.7%-1.4%
Rev Chg 3Y Avg-10.0%-3.8%-3.3%-7.1%-1.4%2.8%-3.5%
Rev Chg Q-5.2%6.4%9.9%7.3%15.0%7.2%7.3%
QoQ Delta Rev Chg LTM-1.5%1.7%2.6%1.9%3.8%1.9%1.9%
Op Inc Chg LTM0.6%-22.2%-34.6%62.3%3.9%7.4%2.2%
Op Inc Chg 3Y Avg-0.1%-1.2%-6.0%68.7%-6.5%7.0%-0.6%
Op Mgn LTM24.5%13.6%9.9%6.8%3.3%12.3%11.1%
Op Mgn 3Y Avg22.8%15.2%12.0%4.0%3.4%12.3%12.1%
QoQ Delta Op Mgn LTM1.8%-2.2%0.2%2.3%0.9%0.1%0.6%
CFO/Rev LTM18.2%13.7%11.2%15.8%6.4%11.4%12.6%
CFO/Rev 3Y Avg17.4%15.5%12.1%15.0%6.9%12.4%13.7%
FCF/Rev LTM13.3%7.7%6.1%11.2%1.5%8.6%8.2%
FCF/Rev 3Y Avg10.9%9.0%5.7%9.0%1.1%9.4%9.0%

Valuation

NGVTCBTEMNASHSCLRPMMedian
NameIngevity Cabot Eastman .Ashland Stepan RPM Inte. 
Mkt Cap2.74.58.43.51.514.94.0
P/S2.31.20.91.90.61.91.6
P/Op Inc9.59.29.628.118.415.412.5
P/EBIT25.49.311.118.715.215.115.2
P/E50.023.819.067.6-562.522.523.1
P/CFO12.89.18.512.19.616.510.9
Total Yield2.0%6.3%9.8%3.6%2.2%6.3%5.0%
Dividend Yield0.0%2.1%4.5%2.2%2.4%1.8%2.2%
FCF Yield 3Y Avg6.7%7.5%5.7%4.8%1.5%5.1%5.4%
D/E0.50.30.60.40.50.20.4
Net D/E0.40.20.50.30.40.20.3

Returns

NGVTCBTEMNASHSCLRPMMedian
NameIngevity Cabot Eastman .Ashland Stepan RPM Inte. 
1M Rtn8.8%5.7%10.1%20.0%17.8%14.0%12.0%
3M Rtn2.9%2.8%1.1%40.0%24.0%17.0%10.0%
6M Rtn7.1%18.8%-2.7%20.8%5.5%1.4%6.3%
12M Rtn54.1%15.4%26.2%49.2%36.4%0.5%31.3%
3Y Rtn40.3%32.3%-1.3%-9.7%-25.2%19.5%9.1%
1M Excs Rtn5.0%-0.4%6.7%14.8%12.6%11.3%9.0%
3M Excs Rtn-0.7%2.7%-4.7%35.7%20.7%10.6%6.6%
6M Excs Rtn-4.2%2.1%-15.0%8.7%-6.9%-11.1%-5.6%
12M Excs Rtn36.9%-7.0%4.6%30.2%14.3%-22.3%9.4%
3Y Excs Rtn-45.1%-38.3%-73.7%-81.3%-97.4%-52.3%-63.0%

Financials

Segment Financials

Revenue by Segment
$ Mil20252024202320222021
Performance Materials (PM)607610586548517
Performance Chemicals (PC)400402426875689
Advanced Polymer Technologies (APT)160189204245186
Total1,1681,2001,2161,6681,392


Operating Income by Segment
$ Mil2019201820172016
Performance Materials (PM)189147122107
Performance Chemicals (PC)1231168057
Total312264202164


Assets by Segment
$ Mil20252024202320222021
Performance Materials (PM)823824738785474
Advanced Polymer Technologies (APT)381568598  
Performance Chemicals (PC)3584991,2181,8771,930
Corporate and other5463697465
Assets of discontinued operations3568   
Total1,6512,0232,6232,7362,469


Price Behavior

Price Behavior
Market Price$77.82 
Market Cap ($ Bil)2.7 
First Trading Date05/02/2016 
Distance from 52W High-0.1% 
   50 Days200 Days
DMA Price$71.72$66.51
DMA Trendupup
Distance from DMA8.5%17.0%
 3M1YR
Volatility32.8%36.6%
Downside Capture95.07118.95
Upside Capture88.00139.93
Correlation (SPY)34.0%40.9%
NGVT Betas & Captures as of 7/31/2026

 1M2M3M6M1Y3Y
Beta1.280.540.900.961.091.40
Up Beta-0.34-0.020.501.011.201.36
Down Beta0.880.530.270.560.901.46
Up Capture176%100%105%111%166%231%
Bmk +ve Days11223567138427
Stock +ve Days10202860129373
Down Capture199%47%141%103%95%109%
Bmk -ve Days11212859114326
Stock -ve Days12233566122377

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with NGVT
NGVT59.5%36.6%1.34-
Sector ETF (XLB)22.6%17.8%0.9958.6%
Equity (SPY)23.3%12.8%1.3640.7%
Gold (GLD)28.5%28.4%0.8722.8%
Commodities (DBC)32.9%19.8%1.32-22.0%
Real Estate (VNQ)14.2%13.8%0.7235.8%
Bitcoin (BTCUSD)-44.2%42.9%-1.2323.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with NGVT
NGVT-1.1%43.4%0.10-
Sector ETF (XLB)6.7%19.1%0.2457.8%
Equity (SPY)13.5%17.2%0.6148.3%
Gold (GLD)18.6%18.6%0.8112.2%
Commodities (DBC)8.2%19.6%0.319.6%
Real Estate (VNQ)2.3%18.9%0.0243.9%
Bitcoin (BTCUSD)8.8%53.0%0.3523.2%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with NGVT
NGVT7.7%43.7%0.32-
Sector ETF (XLB)10.1%20.7%0.4360.1%
Equity (SPY)15.4%17.9%0.7353.6%
Gold (GLD)12.1%16.2%0.614.1%
Commodities (DBC)7.4%18.0%0.3321.2%
Real Estate (VNQ)4.8%20.7%0.2044.6%
Bitcoin (BTCUSD)58.2%66.2%0.9814.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date7152026
Short Interest: Shares Quantity1.2 Mil
Short Interest: % Change Since 63020264.8%
Average Daily Volume0.2 Mil
Days-to-Cover Short Interest5.4 days
Basic Shares Quantity34.7 Mil
Short % of Basic Shares3.5%

Earnings Returns History

Updated 8/7/2026
Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/2026-0.6%9.2% 
5/6/2026-4.9%-8.5%-15.3%
2/25/20261.3%0.4%2.5%
11/5/2025-15.2%-9.8%-0.9%
8/4/202521.3%27.8%41.7%
5/5/202510.4%21.2%16.7%
2/18/20255.3%4.8%-3.5%
10/29/202417.9%22.8%35.1%
...
SUMMARY STATS   
# Positive151311
# Negative81011
Median Positive5.3%4.8%14.2%
Median Negative-6.7%-8.0%-5.9%
Max Positive21.3%27.8%41.7%
Max Negative-15.2%-24.1%-26.4%
Collapse to Preview
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
7/29/2026-0.6%9.2% 
5/6/2026-4.9%-8.5%-15.3%
2/25/20261.3%0.4%2.5%
11/5/2025-15.2%-9.8%-0.9%
8/4/202521.3%27.8%41.7%
5/5/202510.4%21.2%16.7%
2/18/20255.3%4.8%-3.5%
10/29/202417.9%22.8%35.1%
7/31/2024-7.1%-24.1%-14.0%
5/1/20245.6%4.1%-5.9%
2/21/20245.4%0.7%6.2%
11/1/20237.7%-0.8%3.7%
8/2/2023-9.8%-12.1%-12.2%
5/3/2023-8.6%-19.8%-26.4%
2/27/2023-6.0%-7.5%-21.8%
11/2/20228.2%11.7%19.2%
5/4/20225.3%1.8%15.1%
2/23/20220.4%2.1%-0.9%
10/27/20212.5%4.0%-2.6%
7/28/20214.9%-3.5%-4.8%
4/28/20212.8%14.0%9.8%
2/10/2021-6.3%-5.4%6.7%
10/20/20200.2%-2.6%14.2%
SUMMARY STATS   
# Positive151311
# Negative81011
Median Positive5.3%4.8%14.2%
Median Negative-6.7%-8.0%-5.9%
Max Positive21.3%27.8%41.7%
Max Negative-15.2%-24.1%-26.4%

SEC Filings

Expand for More
Report DateFiling DateFiling
06/30/202607/30/202610-Q
03/31/202605/07/202610-Q
12/31/202502/26/202610-K
09/30/202511/06/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202402/19/202510-K
09/30/202410/30/202410-Q
06/30/202408/01/202410-Q
03/31/202405/02/202410-Q
12/31/202302/22/202410-K
09/30/202311/02/202310-Q
06/30/202308/03/202310-Q
03/31/202305/04/202310-Q
12/31/202202/28/202310-K
09/30/202211/03/202210-Q
Collapse to Preview
Report DateFiling DateFiling
06/30/202607/30/202610-Q
03/31/202605/07/202610-Q
12/31/202502/26/202610-K
09/30/202511/06/202510-Q
06/30/202508/05/202510-Q
03/31/202505/06/202510-Q
12/31/202402/19/202510-K
09/30/202410/30/202410-Q
06/30/202408/01/202410-Q
03/31/202405/02/202410-Q
12/31/202302/22/202410-K
09/30/202311/02/202310-Q
06/30/202308/03/202310-Q
03/31/202305/04/202310-Q
12/31/202202/28/202310-K
09/30/202211/03/202210-Q
06/30/202208/03/202210-Q
03/31/202205/05/202210-Q
12/31/202102/24/202210-K
09/30/202110/28/202110-Q
06/30/202107/29/202110-Q
03/31/202104/29/202110-Q
12/31/202002/19/202110-K
09/30/202010/29/202010-Q
06/30/202007/30/202010-Q
03/31/202004/30/202010-Q
12/31/201902/26/202010-K
09/30/201910/30/201910-Q

Recent Forward Guidance

Updated 7/30/2026

Latest: Q2 2026 Earnings Reported 7/29/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Net Sales1.05 Bil1.10 Bil1.15 Bil0 AffirmedGuidance: 1.10 Bil for 2026
2026 Adjusted EBITDA380.00 Mil390.00 Mil400.00 Mil2.0% RaisedGuidance: 382.50 Mil for 2026
2026 Diluted Adjusted EPS55.225.455.6% RaisedGuidance: 4.95 for 2026
2026 Free Cash Flow220.00 Mil232.50 Mil245.00 Mil1.1% RaisedGuidance: 230.00 Mil for 2026

Prior: Q1 2026 Earnings Reported 5/6/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Net Sales1.05 Bil1.10 Bil1.15 Bil-4.3% LoweredGuidance: 1.15 Bil for 2026
2026 Adjusted EBITDA370.00 Mil382.50 Mil395.00 Mil-1.9% LoweredGuidance: 390.00 Mil for 2026
2026 Adjusted EPS4.74.955.2-1.0% LoweredGuidance: 5 for 2026
2026 Free Cash Flow215.00 Mil230.00 Mil245.00 Mil-3.2% LoweredGuidance: 237.50 Mil for 2026

Q4 2025 Earnings Reported 2/25/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue1.10 Bil1.15 Bil1.20 Bil-11.5% Lower NewGuidance: 1.30 Bil for 2025
2026 Adjusted EBITDA380.00 Mil390.00 Mil400.00 Mil-1.9% Lower NewGuidance: 397.50 Mil for 2025
2026 Adjusted EPS4.855.2   
2026 Free Cash Flow225.00 Mil237.50 Mil250.00 Mil   

Q3 2025 Earnings Reported 11/5/2025

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2025 Total Net Sales1.25 Bil1.30 Bil1.35 Bil-1.9% LoweredGuidance: 1.32 Bil for 2025
2025 Total Adjusted EBITDA390.00 Mil397.50 Mil405.00 Mil-1.2% LoweredGuidance: 402.50 Mil for 2025

Insider Activity

Updated 8/4/2026
Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Fisher, Ryan CSVP, Gen. Counsel & SecretaryDirectSell804202673.722,709199,6981,158,969Form
2Dyer, Terrance MSVP, Chief HR OfficerDirectSell601202668.4949633,971493,261Form
Collapse to Preview
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Fisher, Ryan CSVP, Gen. Counsel & SecretaryDirectSell804202673.722,709199,6981,158,969Form
2Dyer, Terrance MSVP, Chief HR OfficerDirectSell601202668.4949633,971493,261Form

Investor Activity (13F)

Updated Aug 8, 2026
13F holdings as of Mar 31, 2026 (Q1 2026)

Active managers (13F portfolio over $250M, at least 3 holdings) with a position over $5M that is either over 10% of their portfolio or held in a concentrated book of 50 or fewer total positions. Index/ETF, sovereign, bank, community-bank and charitable/donor-advised filers are excluded.

Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Simcoe Capital Management, LLC$69.9 Mil13.0%14Hold13F
Harvey Partners, LLC$53.0 Mil4.3%45ADD +18.1%13F
Southernsun Asset Management, LLC$17.9 Mil2.6%31TRIM -8.0%13F
Maple Rock Capital Partners Inc.$43.0 Mil1.4%44TRIM -10.6%13F
Alpha Wave Global, LP$6.1 Mil0.8%20TRIM -55.2%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Harvey Partners, LLC$53.0 Mil4.3%45ADD +18.1%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Alpha Wave Global, LP$6.1 Mil0.8%20TRIM -55.2%13F
Maple Rock Capital Partners Inc.$43.0 Mil1.4%44TRIM -10.6%13F
Southernsun Asset Management, LLC$17.9 Mil2.6%31TRIM -8.0%13F
Active ManagerValue% of PortfolioTotal PositionsQoQFiling
Simcoe Capital Management, LLC$69.9 Mil13.0%14Hold13F
Harvey Partners, LLC$53.0 Mil4.3%45ADD +18.1%13F
Maple Rock Capital Partners Inc.$43.0 Mil1.4%44TRIM -10.6%13F
Southernsun Asset Management, LLC$17.9 Mil2.6%31TRIM -8.0%13F
Alpha Wave Global, LP$6.1 Mil0.8%20TRIM -55.2%13F
Core Cache Last Updated: 8/7/2026